The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
SDF-1 is both necessary and sufficient to promote proliferative retinopathy
Open accessAbstract
Diabetic retinopathy is the leading cause of blindness in working-age adults. It is caused by oxygen starvation in the retina inducing aberrant formation of blood vessels that destroy retinal architecture. In humans, vitreal stromal cell-derived factor-1 (SDF-1) concentration increases as proliferative diabetic retinopathy progresses. Treatment of patients with triamcinolone decreases SDF-1 levels in the vitreous, with marked disease improvement. SDF-1 induces human retinal endothelial cells to increase expression of VCAM-1, a receptor for very late antigen-4 found on many hematopoietic progenitors, and reduce tight cellular junctions by reducing occludin expression. Both changes would serve to recruit hematopoietic and endothelial progenitor cells along an SDF-1 gradient. We have shown, using a murine model of proliferative adult retinopathy, that the majority of new vessels formed in response to oxygen starvation originate from hematopoietic stem cell-derived endothelial progenitor cells. We now show that the levels of SDF-1 found in patients with proliferative retinopathy induce retinopathy in our murine model. Intravitreal injection of blocking antibodies to SDF-1 prevented retinal neovascularization in our murine model, even in the presence of exogenous VEGF. Together, these data demonstrate that SDF-1 plays a major role in proliferative retinopathy and may be an ideal target for the prevention of proliferative retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G. L., & Smith, L. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10457 · Cited by 1,260
Yamaguchi, J.-I., Kusano, K. F., Masuo, O., Kawamoto, A., Silver, M., Murasawa, S., Bosch-Marce, M., Masuda, H., Losordo, D. W., Isner, J. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000055313.77510.22 · Cited by 1,149
Intravitreal triamcinolone for refractory diabetic macular edema
Martidis, A., Duker, J. S., Greenberg, P. B., Rogers, A. H., Puliafito, C. A., Reichel, E., & Baumal, C. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)00975-2 · Cited by 1,032
Vascular endothelial growth factors and angiogenesis in eye disease
Witmer, A. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00043-5 · Cited by 927
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., & Janjic, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20556 · Cited by 744
Preliminary Report on Effects of Photocoagulation Therapy
(1976) · American Journal of Ophthalmology · doi:10.1016/0002-9394(76)90292-0 · Cited by 723
Grant, M. B., May, W. S., Caballero, S., Brown, G. A. J., Guthrie, S. M., Mames, R. N., Byrne, B. J., Vaught, T., Spoerri, P. E., Peck, A. B., et al. (2002) · Nature Medicine · doi:10.1038/nm0602-607 · Cited by 665
Self-citationLevin, L. A., NILSSON, S. F. E., Hoeve, J. N. V., Wu, S. M.-S., Kaufman, P. L., & Alm, A. (2011) · Andalas University Repository (Andalas University) · Cited by 578
Intravitreal Injection of Triamcinolone for Diffuse Diabetic Macular Edema
Jonas, J. B. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.1.57 · Cited by 563
Salcedo, R., Wasserman, K., Young, H. A., Grimm, M. C., Howard, O. M. Z., Anver, M. R., Kleinman, H. K., Murphy, W. J., & Oppenheim, J. J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65365-5 · Cited by 540
Hematopoietic Stem Cells Are Uniquely Selective in Their Migratory Response to Chemokines
Wright, D. E., Bowman, E. P., Wagers, A. J., Butcher, E. C., & Weissman, I. L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011284 · Cited by 517
Synthesis of von Willebrand Factor by Cultured Human Endothelial Cells
Jaffe, E. A., Hoyer, L. W., & Nachman, R. L. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.5.1906 · Cited by 484
Chen, Y., Wiesmann, C., Fuh, G., Li, B., Christinger, H. W., McKay, P., de Vos, A. M., & Lowman, H. B. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3192 · Cited by 448
Intraocular pressure after intravitreal injection of triamcinolone acetonide
Jonas, J. B. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.1.24 · Cited by 422
Salvucci, O., Yao, L., Villalba, S., Sajewicz, A., Pittaluga, S., & Tosato, G. (2002) · Blood · doi:10.1182/blood.v99.8.2703 · Cited by 347
Treatment of Intraocular Proliferation with Intravitreal Injection of Triamcinolone Acetonide
Tano, Y., Chandler, D., & Machemer, R. (1980) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)75196-7 · Cited by 338
Otani, A., Kinder, K., Ewalt, K., Otero, F. J., Schimmel, P., & Friedlander, M. (2002) · Nature Medicine · doi:10.1038/nm744 · Cited by 328
Wilson, C. A. (1992) · Archives of Ophthalmology · doi:10.1001/archopht.1992.01080200135041 · Cited by 282
Lazarini, F., Tham, T. N., Casanova, P., Arenzana‐Seisdedos, F., & Dubois‐Dalcq, M. (2003) · Glia · doi:10.1002/glia.10139 · Cited by 280
Role of the CXCR4/SDF-1 chemokine axis in circulating neutrophil homeostasis
Suratt, B. T., Petty, J. M., Young, S. K., Malcolm, K. C., Lieber, J. G., Nick, J. A., Gonzalo, J.-A., Henson, P. M., & Worthen, G. S. (2004) · Blood · doi:10.1182/blood-2003-10-3638 · Cited by 274
The Lack of Toxicity of Intravitreally Administered Triamcinolone Acetonide
McCuen, B. W., Bessler, M., Tano, Y., Chandler, D., & Machemer, R. (1981) · American Journal of Ophthalmology · doi:10.1016/0002-9394(81)90013-1 · Cited by 262
SDF-1 Activity on Microvascular Endothelial Cells
Mirshahi, F., Pourtau, J., Li, H., Muraine, M., Trochon, V., Legrand, E., Vannier, J.-P., Soria, J., Vasse, M., & Soria, C. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00292-9 · Cited by 232
Kijowski, J., Baj‐Krzyworzeka, M., Majka, M., Reca, R., Marquez, L. A., Christofidou‐Solomidou, M., Janowska‐Wieczorek, A., & Ratajczak, M. Z. (2001) · STEM CELLS · doi:10.1634/stemcells.19-5-453 · Cited by 224
Hatch, H. M., Zheng, D., Jorgensen, M. L., & Petersen, B. E. (2002) · Cloning and Stem Cells · doi:10.1089/153623002321025014 · Cited by 222
Secondary Chronic Open-Angle Glaucoma After Intravitreal Triamcinolone Acetonide
Jonas, J. B. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.5.729 · Cited by 218
Rafii, S., Heissig, B., & Hattori, K. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301723 · Cited by 175
The Role of Adult Bone Marrow-Derived Stem Cells in Choroidal Neovascularization
Sengupta, N., Caballero, S., Mames, R. N., Butler, J. M., Scott, E. W., & Grant, M. B. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0342 · Cited by 154
Self-citationRole of astrocytes in the control of developing retinal vessels.
Zhang, Y., & Stone, J. (1997) · PubMed · Cited by 132
The Regulation of Hematopoietic Stem Cell and Progenitor Mobilization by Chemokine SDF-1
Hattori, K., Heissig, B., & Rafii, S. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819021000037985 · Cited by 121
Neuhaus, T., Stier, S., Totzke, G., Grünewald, E., Fronhoffs, S., Sachinidis, A., Vetter, H., & Ko, Y. D. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00262.x · Cited by 86
Grant, M. B., & Guay, C. (1991) · PubMed · Cited by 79
Self-citationThe nitric oxide pathway modulates hemangioblast activity of adult hematopoietic stem cells
Guthrie, S. M., Curtis, L. M., Mames, R. N., Simon, G. G., Grant, M. B., & Scott, E. W. (2004) · Blood · doi:10.1182/blood-2004-09-3415 · Cited by 78
Self-citation
Cited by
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Duh, E. J., Sun, J. K., & Stitt, A. W. (2017) · JCI Insight · doi:10.1172/jci.insight.93751 · Cited by 1,057
Vascular endothelial growth factor in eye disease
Penn, J. S., Madan, A., Caldwell, R. B., Bartoli, M., Caldwell, R. W., & Hartnett, M. E. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.001 · Cited by 762
Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska‐Wieczorek, A., Ratajczak, J., & Ratajczak, M. Z. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0342 · Cited by 759
Jin, D. K., Shido, K., Kopp, H.-G., Petit, I., Shmelkov, S. V., Young, L. M., Hooper, A. T., Amano, H., Avecilla, S. T., Heissig, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1400 · Cited by 646
The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis
Petit, I., Jin, D., & Rafii, S. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.05.007 · Cited by 603
Metadata
- Authors
- Butler, J. M., Guthrie, S. M., Koc, M., Afzal, A., Caballero, S., Brooks, H. L., Mames, R. N., Segal, M. S., Grant, M. B., & Scott, E. W.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-01-03
- Volume
- 115
- Issue
- 1
- Pages
- 86-93
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2074344799
- Cited by
- 263
- References
- 34
- FWCI
- 18.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.